KWF
Implementation of Biomarkers
12:00 noon; Full proposal deadline 23 February 2027, 12:00 noon
Last updated:
The KWF Implementation of Biomarkers programme funds multidisciplinary consortia €1-€4 million over 3-5 years to embed clinically validated biomarkers (technology readiness level 7-9) into routine oncology care across the Netherlands. Consortia must include at least four parties (academic, clinical, industry, and patient representatives), a mandatory health technology assessment specialist, and a patient oversight committee. This call is unique for prioritising implementation science and real-world integration over discovery research.
Details
| Funder | KWF |
| Budget | €1M–€4M |
| Deadline | 20 October 2026 |
| Duration | 3-5 years |
| Consortium | Required — multidisciplinary consortium, minimum 4 participating parties (may include private partners) |
| Application | 2-stage: pre-proposal (deadline 20 October 2026) → full proposal (deadline 23 February 2027), followed by interviews May 2027 and funding decision June 2027 |
| TRL | 7-9 |
| Frequency | Annual |
| Eligible countries | NL |
Eligibility & scope
Programme for phase III studies and implementation of validated clinical-grade biomarkers (TRL7-9) into routine Dutch oncology care. Requires a multidisciplinary consortium with min. 4 parties, a project manager, HTA specialist, patient perspective embedded, and a KWF-approved steering committee.
Who Should Apply
- •Multidisciplinary consortia with minimum 4 participating organisations (academic, hospital, industry, patient advocates)
- •Experienced researchers and clinicians (PhD candidates discouraged)
- •Teams with a validated biomarker at TRL 7-9 ready for clinical implementation
- •Applicants able to embed a health technology assessment specialist and patient steering committee
- •Dutch institutions hosting the consortium lead
Key Dates
- •Pre-proposal deadline 20 October 2026 (12:00 noon); full proposal deadline 23 February 2027 (12:00 noon)
- •Two-stage: pre-proposal screening → full proposal and interview (May 2027) → funding decision June 2027
- •Project duration 3-5 years
Tips for Applicants
- ✓Assemble your consortium and HTA specialist early; late additions weaken scoring and KWF may reject incomplete teams at pre-proposal triage.
- ✓The steering committee and patient representatives must be named and active from the pre-proposal stage; token inclusion fails the embedded patient perspective criterion.
- ✓Budget co-funding from industry or regional cancer networks; KWF favours risk-shared models and is more likely to fund if private-sector commitment is explicit.
Frequently Asked Questions
What is the budget for the KWF Implementation of Biomarkers call?
€1-€4 million per project over 3-5 years. Consortia are encouraged to seek co-funding from industry or other partners.
Who must be part of a consortium for the KWF Implementation of Biomarkers?
Minimum four parties including academic/clinical researchers, an HTA specialist, industry or implementation partners, and patient representatives. A KWF-approved steering committee is mandatory.
What is meant by TRL 7-9 in this call?
Technology Readiness Level 7-9 describes biomarkers that have been clinically validated and are ready for implementation into real-world healthcare settings, not early-stage research tools.
Is the KWF Implementation of Biomarkers call annual?
Yes, KWF runs this call annually with pre-proposal opens in late August and deadlines in October (pre-proposal) and February (full proposal).
Can PhD candidates lead a team on the KWF Implementation of Biomarkers?
PhD candidates are strongly discouraged; the call targets experienced researchers and clinicians.
Related on Grantsby
- KWF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
Validation of Biomarkers
KWFDeadline: 20 Oct 2026€0.8M–€2MPipeline
KWFDeadline: 8 Dec 2026€1M–€2.5M (Phase I/I-II); €1M–€5M (Phase II/III)Next steps
CancerfondenDeadline: 15 Dec 2026Proof of Concept
KWFDeadline: 22 Sept 2026Up to €150,000 incl. VATCDD Scouting Programme
KWFUp to €2 million per project
Browse Related
Could Implementation of Biomarkers be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →